| Literature DB >> 25753635 |
Atteneri López-Arencibia1, Daniel García-Velázquez2, Carmen M Martín-Navarro3, Ines Sifaoui4, María Reyes-Batlle3, Jacob Lorenzo-Morales3, Ángel Gutiérrez-Ravelo2, José E Piñero3.
Abstract
The in vitro activity of a novel group of compounds, hexaazatrinaphthylene derivatives, against two species of Leishmania is described in this study. These compounds showed a significant dose-dependent inhibition effect on the proliferation of the parasites, with 50% inhibitory concentrations (IC(50)s) ranging from 1.23 to 25.05 μM against the promastigote stage and 0.5 to 0.7 μM against intracellular amastigotes. Also, a cytotoxicity assay was carried out to in order to evaluate the possible toxic effects of these compounds. Moreover, different assays were performed to determine the type of cell death induced after incubation with these compounds. The obtained results highlight the potential use of hexaazatrinaphthylene derivatives against Leishmania species, and further studies should be undertaken to establish them as novel leishmanicidal therapeutic agents.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25753635 PMCID: PMC4394827 DOI: 10.1128/AAC.00226-15
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191